Surface modulation of wounds heal by inhalants! Novel drug based treatment for...
Surface modulation of wounds heal by inhalants! Novel drug based treatment for excessive scars and chronic wounds.
The innovative concept of the ERC Starting Grant project Keratinocytes and Matrix metalloproteinases: driving force of skin wound contraction? was to use inhalants for skin wounds and it proved to be excellent and functional. Surf...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto SUMOWO
Duración del proyecto: 20 meses
Fecha Inicio: 2016-04-14
Fecha Fin: 2017-12-31
Líder del proyecto
UNIVERSITAET BREMEN
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
150K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The innovative concept of the ERC Starting Grant project Keratinocytes and Matrix metalloproteinases: driving force of skin wound contraction? was to use inhalants for skin wounds and it proved to be excellent and functional. Surface Modulation of Wounds (SUMOWO) with these anti-inflammatory, pro-migratory and anti-fibrotic compounds will be beneficial for chronic wound healing and reduce excessive scarring. This novel drug-based treatment strategy marks a novel era of wound care. A clinical phase 1 study on healthy volunteers is planned to show the product’s safety and tolerability for skin use – the first step towards clinical application. The goal of SUMOWO is to deliver clinical proof of concept, to provide a thorough market analysis with contact to key-players, to secure our intellectual property rights on an international platform, to accelerate commercial exploitation and ultimately, to restore patients’ life quality.